The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 04, 2012
Filed:
Dec. 30, 2009
Maria Del Carmen Domínguez Horta, Ciudad de La Habana, CU;
Gabriel Ramón Padrón Palomares, Ciudad de La Habana, CU;
Nelia López Marin, Ciudad de La Habana, CU;
Norailys Lorenzo Perez, Ciudad de La Habana, CU;
Ariana Barberá Betancourt, Ciudad de La Habana, CU;
Ariadna Hernández Garcia, Ciudad de La Habana, CU;
Vivian Morera Cordova, Ciudad de La Habana, CU;
Carelia Cosme Diaz, Ciudad de La Habana, CU;
Nelson J. Merino Garcia, Ciudad de La Habana, CU;
Ariel Vázquez Bonachea, Ciudad de La Habana, CU;
José Suárez Alba, Ciudad de La Habana, CU;
Maria del Carmen Domínguez Horta, Ciudad de La Habana, CU;
Gabriel Ramón Padrón Palomares, Ciudad de La Habana, CU;
Nelia López Marin, Ciudad de La Habana, CU;
Norailys Lorenzo Perez, Ciudad de La Habana, CU;
Ariana Barberá Betancourt, Ciudad de La Habana, CU;
Ariadna Hernández Garcia, Ciudad de La Habana, CU;
Vivian Morera Cordova, Ciudad de La Habana, CU;
Carelia Cosme Diaz, Ciudad de La Habana, CU;
Nelson J. Merino Garcia, Ciudad de La Habana, CU;
Ariel Vázquez Bonachea, Ciudad de La Habana, CU;
José Suárez Alba, Ciudad de La Habana, CU;
Centro de Ingenieria Genetica Y Biotecnologia, Ciudad de La Habana, CU;
Abstract
Peptides of human heat shock protein of 60 kDa, that constitute epitopes for T cells, as well as their derived peptides, which are modified at the contact sites with the MHC molecule, are useful to induce mechanisms of peripheral tolerance, in particular mechanisms of anergy or mediated by clones of regulatory T cells in patients with Rheumatoid Arthritis. The invention also refers pharmaceutical compositions comprising such peptides for the treatment of Rheumatoid Arthritis.